Probabilistic Graphical Model for Adolescent MDD Treatment Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating major depressive disorder (MDD) in adolescents lack effective prediction tools for treatment outcomes, particularly in determining which adolescents will benefit from antidepressant therapy, dosage adjustments, and maintenance treatment, and there is a need for improved clinical practice algorithms in primary care settings.
Innovation Solution
A computer-implemented method using machine learning models, specifically probabilistic graphical models (PGMs) coupled with unsupervised learning, to predict treatment outcomes for adolescents with MDD by analyzing symptom measure data at different time points, identifying symptom classes, and generating predictions for treatment responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If logistic regression models are used to predict treatment response, then the rate of overall depressive symptom improvement can be captured, but the inherent heterogeneity of symptom presentations and treatment trajectories cannot be captured
Solution Approach 1:
The patent segments the overall symptom improvement into distinct symptom clusters (e.g., cognitive symptoms, somatic symptoms, interpersonal symptoms) that can be independently analyzed. This segmentation allows the model to capture heterogeneity in different symptom dimensions while maintaining predictive accuracy for overall treatment response.
Solution Approach 2:
The patent introduces temporal dimensionality by analyzing symptom trajectories across multiple time points during treatment rather than relying on a single baseline measurement. This dimensional expansion enables the model to capture dynamic treatment responses and heterogeneous treatment trajectories over time.
2Adaptability or versatility
If symptom clusters are identified without thresholds, then differential response to treatment can be examined, but interpretable predictions of acute treatment course cannot be derived
Solution Approach 1:
The patent transforms continuous symptom severity measurements into discrete symptom class categories with defined thresholds. This parameter transformation creates interpretable treatment response predictions (e.g., minimal, moderate, marked improvement) while preserving the underlying symptom cluster structure identified through unsupervised learning.
3Measurement precision
If machine learning models are used to predict treatment outcomes, then accurate predictions can be generated, but the models may lack interpretability for clinical decision-making
Solution Approach 1:
The patent introduces symptom classes as intermediary categories that bridge the gap between complex machine learning model outputs and clinically interpretable predictions. These symptom classes serve as mediators that translate model predictions into meaningful treatment outcome categories that clinicians can understand and act upon.
Data Source
AI summary
Likely outcomes of a treatment of an adolescent patient who has major depressive disorder (“MDD”) using machine learning. Symptoms reported at one or two points in time are input to a suitably trained machine learning model, generating output that indicate a prediction of the most likely outcome of a particular treatment at a third point in time, a future severity of symptoms, or another clinical course of action. The treatment outcome can include the likelihood of remission, response to drug, selection of the drug most likely to give positive outcomes, and so on. The machine learning model can implement a probabilistic graphical model, as an example.